Current guidelines recommend S-IGF-1 measurement in patients with several acromegaly-associated conditions, including sleep apnea, type 2 diabetes mellitus, debilitating arthritis, carpal tunnel syndrome, hyperhidrosis, and hypertension [6]. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.